Richard Lewis
Richard Lewis Bolton, Jr., Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20130179786 | SYSTEM FOR RECOMMENDING MOVIE FILMS AND OTHER ENTERTAINMENT OPTIONS - Described herein is a online, network-based system that recommends to a user media items for the user's enjoyment, based upon the user's emotional goal, i.e., the user's goal with respect to the user's emotions and thoughts after viewing, listening or reading the media item. The system is used on and in conjunction with a computer, such as a desk top or laptop device, or a tablet device, smart phones, and other internet-enabled devices. The system may be used to recommend a film based on the user's mood at the time the user is using the system, or based on what the user anticipates his or her mood to be at the time the film will be viewed. However, preferably the system is used to recommend a film based on the emotional state that the user would like to create for him or herself and/or for others who will be viewing the film with the user (such as to raise the film viewer(s)' spirits, to battle the forces of evil, to understand life, etc.). | 07-11-2013 |
Richard Lewis Clarke, Bristol GB
Patent application number | Description | Published |
---|---|---|
20160054534 | OPTICAL FIBRE INSTALLATION IN FLEXIBLE RISER - A method and apparatus for providing a fibre element are disclosed. The method includes the steps of opening a first control valve element ( | 02-25-2016 |
Richard Lewis Easeman, Brentford GB
Patent application number | Description | Published |
---|---|---|
20140294919 | VACCINES - The present invention relates to efficient devices for administration of pharmaceutical agents into the skin of the human body. In particular the present invention provides devices for vaccination into the skin. The present invention provides a pharmaceutical agent delivery device having skin-piercing portion comprising a solid reservoir medium containing the pharmaceutical agent, wherein the reservoir medium is coated onto the skin piercing portion. Alternatively, the skin piercing portion may consist of the solid pharmaceutical agent reservoir medium. The pharmaceutical delivery devices are proportioned such that agent is delivered into defined layers of the skin, and preferred delivery devices comprise skin-piercing portions that deliver the pharmaceutical agent into the epithelium or the dermis. Preferred reservoir media comprise sugars, and in particular stabilising sugars that form a glass such as lactose, raffinose, trehalose or sucrose. Furthermore, vaccine delivery devices for administration of vaccines into the skin are provided, methods of their manufacture, and their use in medicine. | 10-02-2014 |
Richard Lewis Easeman, Middlesex GB
Patent application number | Description | Published |
---|---|---|
20120070436 | ANTIGEN-BINDING PROTEINS - The present invention relates to antigen binding proteins comprising a receptor-Fc fusion which is linked to one or more epitope-binding domains, methods for making such proteins, and uses thereof. | 03-22-2012 |
Richard Lewis Fabini, Cardiff-By-The-Sea, CA US
Patent application number | Description | Published |
---|---|---|
20120139328 | AUTOMOTIVE VEHICLE BRAKE SYSTEM - An automotive vehicle braking system includes a hydraulic brake system in communication with a regenerative brake system. The regenerative brake system has both a fixed system logic portion and a user-adjustable system logic portion. The fixed system logic of the regenerative brake system is driven by a brake member displacement. | 06-07-2012 |
20120139329 | REGENERATIVE BRAKING SYSTEM - An automotive vehicle braking system includes a regenerative brake system operable upon a deceleration request from at least one of an acceleration member and a braking member. At least a portion of the deceleration request is adjustable by a user when the deceleration request is provided by the acceleration member. | 06-07-2012 |
20120143410 | INTERACTIVE DRIVER SYSTEM FOR AN ELECTRIC VEHICLE - An interactive driver system is provided that alleviates range anxiety for the driver of an electric vehicle. The system includes: a range monitor module that determines range of the electric vehicle and identifies a given condition of the vehicle in which the range of the vehicle may be exceeded during ongoing operation of the vehicle; a load monitor module that identifies one or more electric loads being placed on a battery of the electric vehicle; and a driver notification module that presents suggestions on a display of the vehicle to the driver of the vehicle for reducing energy consumption by the vehicle upon occurrence of the given condition, where the suggestions relate to the identified electric loads. The suggestions presented to the driver preferably identify an action to be taken by the driver that reduces energy consumption and an associated change in the range of the vehicle if the action is taken by the driver. | 06-07-2012 |
Richard Lewis Jarvest, Hertfordshire GB
Patent application number | Description | Published |
---|---|---|
20080221158 | Novel 14 and 15 Membered Ring Compounds - The present invention relates to 15-membered macrolides substituted at the 4″ position of formula (I) | 09-11-2008 |
Richard Lewis Thompson, County Durham GB
Patent application number | Description | Published |
---|---|---|
20100036054 | NOVEL SURFACE ACTIVE POLYMERIC SYSTEMS - A polymer comprising a bulk polymer or copolymer P | 02-11-2010 |
Richard Lewis Veech, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20100298294 | KETONE BODIES AND KETONE BODY ESTERS AS BLOOD LIPID LOWERING AGENTS - The subject disclosure provides compositions for reducing serum cholesterol and/or triglyceride levels in subjects. These compositions can comprise racemic β-hydroxybutyrate or D-β-hydroxybutyrate, optionally in the acid form, physiologically compatible salts of racemic β-hydroxybutyrate or D-β-hydroxybutyrate, esters of D-β-hydroxybutyrate, oligomers of D-β-hydroxybutyrate containing from 2 to 20 or more monomeric units in either linear or cyclic form, racemic 1,3 butandiol or R-1,3 butandiol alone and can be, optionally, administered in conjunction with a low fat diet to a subject. Alternatively, compositions comprising racemic β-hydroxybutyrate or D-β-hydroxybutyrate, optionally in the acid form, physiologically compatible salts of racemic β-hydroxybutyrate or D-β-hydroxybutyrate, esters of D-β-hydroxybutyrate, oligomers of D-β-hydroxybutyrate containing from 2 to 20 or more monomeric units in either linear or cyclic form, racemic 1,3 butandiol, R-1,3 butandiol or combinations thereof can be formulated as nutritional supplements (also referred to as nutritional compositions) or incorporated into therapeutic compositions containing a) anti-hypertensive agents; b) anti-inflammatory agents; c) glucose lowering agents; or d) anti-lipemic agents) which are administered to a subject, optionally in combination with a low fat diet, in order to cause a reduction or lowering of: serum cholesterol levels; triglyceride levels; serum glucose levels, serum homocysteine levels, inflammatory proteins (e.g., C reactive protein) and/or hypertension in treated subjects. Alternatively, compositions disclosed herein can be administered alone, or in combination with other therapeutic agents to prevent or reverse vascular disease. | 11-25-2010 |
20110237666 | HYDROXYBUTYRATE ESTER AND MEDICAL USE THEREOF - A compound which is 3-hydroxybutyl 3-hydroxybutyrate enantiomerically enriched with respect to (3R)-hydroxybutyl (3R)-hydroxybutyrate of formula (I) is an effective and palatable precursor to the ketone body (3R)-hydroxybutyrate and may therefore be used to treat a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, for instance a condition where weight loss or weight gain is implicated, or to promote alertness or improve cognitive function, or to treat, prevent or reduce the effects of neurodegeneration, free radical toxicity, hypoxic conditions or hyperglycaemia. | 09-29-2011 |
20120064611 | Process For The Preparation of (3R)-Hydroxybutyl (3R) -Hydroxybutyrate By Enzymatic Enantioselective Reduction Employing Lactobacillus Brevis Alcohol Dehydrogenase - A process for producing a compound which is (3R)-hydroxybutyl(3R)-hydroxybutyrate of formula (I) which process comprises submitting, to enantioselective reduction, a compound of the following formula (II), (III) or (IV). | 03-15-2012 |
20140194509 | HYDROXYBUTYRATE ESTER AND MEDICAL USE THEREOF - A compound which is 3-hydroxybutyl 3-hydroxybutyrate enantiomerically enriched with respect to (3R)-hydroxybutyl (3R)-hydroxybutyrate of formula (I) is an effective and palatable precursor to the ketone body (3R)-hydroxybutyrate and may therefore be used to treat a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, for instance a condition where weight loss or weight gain is implicated, or to promote alertness or improve cognitive function, or to treat, prevent or reduce the effects of neurodegeneration, free radical toxicity, hypoxic conditions or hyperglycaemia. | 07-10-2014 |
20140308719 | PROCESS FOR PRODUCING (R)-3-HYDROXYBUTYL (R)-3-HYDROXYBUTYRATE - Embodiments of the present invention are directed to processes for the production of (R)-3-hydroxybutyl (R)-3-hydroxybyrate. Poly (R)-3-hydroxybyrate is transesterified with an alcohol, to form a first ester portion and a second ester portion. The first ester portion is reduced to the diol to form a diol portion and the diol portion is reacted with the second ester portion to produce (R)-3-hydroxybutyl (R)-3-hydroxybyrate. | 10-16-2014 |
20160030314 | COMPOUND FOR USE IN PROTECTING SKIN - A method of protecting animal tissue particularly skin, from damage caused by radiation exposure, by contacting the tissue with a ketone ester, a method of protecting skin, reducing the deterioration of skin or maintaining or improving the properties of skin by applying topically to the skin a ketone body comprising (R)-3-hydroxybutyrate moieties is disclosed. A ketone body comprising (R)-3-hydroxybutyrate moieties, especially enantiomerically enriched R-1,3-hydroxybutyl-(R)-3-hydroxybutyrate, for such uses is also provided. | 02-04-2016 |